Clinical Trials Directory

Trials / Completed

CompletedNCT01877941

Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The specific aim of this study is to assess whether a device approved by the FDA to measure pulse oximetry can accurately estimate cardiac output.

Detailed description

We will compare three methods for measuring cardiac output: esCCO, PAC, and ECOM. Cardiac output is an important physiological parameter that must be monitored closely during surgery and during an Intensive Care Unit (ICU) stay. The use of a pulmonary artery catheter (PAC) has been the gold standard for accurate cardiac output (CO) measurement. This method requires a catheter to be inserted into the pulmonary artery and cardiac output is indicated by the speed that a temperature gradient dissipates. While the use of the pulmonary artery catheter is widespread, inserting the pulmonary artery catheter is risky, time consuming and requires a high level of skill. For these reasons, new devices have been developed to measure cardiac output. A second method typically used is called ECOM (Endotracheal Cardiac Output Monitor). A device is inserted into the patient's throat that calculates cardiac output by measuring how electricity moves through the patient's chest. The third method, estimated Continuous Cardiac Output (esCCO), uses sensors placed on the patient's finger, arm and chest to calculate Pulse Wave Transit Time (PWTT); the time it takes for the heart beat pulse to travel through the patient's body. The esCCO system is FDA approved for safety and efficacy to measure noninvasive blood pressure and pulse oximetry. The purpose of this study is to assess whether the PSTT calculation provides a cardiac output measure that is comparable to the other methods. This study is sponsored by Nihon Kohden Corporation who owns and manufactures the esCCO system.

Conditions

Interventions

TypeNameDescription
DEVICEPulmonary Artery Catheter (PAC)A catheter is inserted into the pulmonary artery, through the internal jugular vein; cardiac output is indicated by the speed that a temperature gradient dissipates.
DEVICEEndotracheal Cardiac Output Monitor (ECOM)An FDA-approved medical device is inserted into the patient's throat; cardiac output is calculated by measuring how electricity moves through the chest.
DEVICEEstimated Continuous Cardiac Output (esCCO)Sensors are placed on the arm, finger and leg to calculate Pulse Wave Transit Time (PWTT); the time it takes for the pulse of the heartbeat to travel through the body.

Timeline

Start date
2012-12-01
Primary completion
2013-11-01
Completion
2013-12-01
First posted
2013-06-14
Last updated
2015-01-01
Results posted
2015-01-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01877941. Inclusion in this directory is not an endorsement.